|Articles|February 1, 2008

Do all infants with UTIs need a VCUG?

Voiding cystourethrography not always indicated for infants with UTI.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

FDA approves dolutegravir dispersible tablets for HIV-infected newborns

FDA approves dolutegravir dispersible tablets for HIV-infected newborns

ByMorgan Ebert, Executive Editor

August 26th 2026

Study finds no association between neonatal circumcision and autism diagnosis | Image Credit: © nataliaderiabina - stock.adobe.com.

Study finds no association between neonatal circumcision and autism diagnosis

ByMorgan Ebert, Executive Editor

August 3rd 2026

Prenatal therapy improves outcomes in fetal renal failure | Image credit: © guruXO - stock.adobe.com.X

Prenatal therapy improves outcomes in fetal renal failure

ByMorgan Ebert, Executive Editor

July 23rd 2026

Text-message video intervention does not improve infant safe sleep practices in low-income families | Image Credit: © EUDPic - stock.adobe.com

Text-message video intervention does not improve infant safe sleep practices in low-income families

ByMorgan Ebert, Executive Editor

July 23rd 2026

Joyce Woo, MD, on how rapid diagnosis and transfer remain critical in severe heart defects

Joyce Woo, MD, on how rapid diagnosis and transfer remain critical in severe heart defects

ByJoyce Woo, MD, MS

July 20th 2026

Latest CME

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Jordan Axelrad, MD, MPH, FACG, FCCF; Jessica R. Allegretti, MD, MPH; Florian Rieder, MD

Trending on Contemporary Pediatrics

Abbott launches first ready-to-feed whole milk infant formula in the U.S.

FDA news in pediatrics: August 2026

Semaglutide improves BMI category in children aged 6 to 11 years in phase 3 trial

The unharmonious 2026 child and adolescent immunization schedule

ARTEMIS trial data show Bifidobacterium-HMO synbiotic is safe and colonizes the infant, toddler gut